Minidiab 5mg tablets contain the active ingredient glibenclamide, which belongs to a class of drugs called sulfonylureas. It is used to lower blood sugar levels in patients with type 2 diabetes.
The recommended dose of Minidiab 5mg tablets varies depending on the individual's blood glucose levels and response to treatment. It is usually taken once a day with breakfast or the first main meal of the day.
Glibenclamide works by stimulating the pancreas to release insulin, which helps lower blood sugar levels. It is important to take Minidiab 5mg tablets as directed by a healthcare professional and to monitor blood glucose levels regularly to ensure optimal treatment.
Common side effects of glibenclamide may include nausea, vomiting, diarrhea, and stomach upset. In rare cases, glibenclamide may cause serious side effects such as hypoglycemia (low blood sugar), liver problems, and blood disorders.
It is important to inform your healthcare provider of any other medications you are taking before starting treatment with Minidiab 5mg tablets, as they may interact with certain medications. It is also important to inform your healthcare provider if you are pregnant, breastfeeding, or planning to become pregnant.
If you experience any adverse effects or have any concerns about the use of Minidiab 5mg tablets, it is important to consult with your healthcare provider immediately.